In addition, some preclinical studies suggest that cetuximab inhibits the proliferation of colon cancer cell lines expressing EGFR and enhances the antitumor activity of chemotherapy and radiotherapy [25]. This evidence concerns the gene EGFR and colonic neoplasm.